Defense TechConnect

FEBRUARY 17, 2021


Diagnostic technologies for identification of SARS-CoV-2 from human nasal, buccal, or saliva samples.


Sixty-nine (69) Entries were received from an international community of corporations, universities and government labs. This community included a total of 50 non-traditional institutions (primarily small organizations with less than 20 employees) featuring prototype level solutions. The aim of this call was rapid and efficient diagnosis, with emphasis on rapid point of care testing and diagnostics. While submissions that required saliva or nasal samples were dominant, seven (7) submissions were focused on breath analysis with one submission involving analysis of chest x-rays. Functionally, all submissions categorized into 4 main technical groups: 1) nucleic acid amplification; 2) biosensors; 3) optical spectroscopy; and 3) other innovative methods.

Highlights from the pool of Entries include:

  • >25% of the Entries include direct SARS-CoV-2 measurements or data.
  • Nucleic acid amplification was featured in 20 of the submissions
    primarily on analysis of saliva samples, involving improvements to
    PCR and LAMP, reduction of the number of steps in the protocol,
    self-diagnosis solutions, and use of CRISPR technology.
  • Most biosensor solutions prioritized ease of self-administration and
    emphasized material innovations (nanocomposites, molecularly
    imprinted polymers), as well as novel methods using photonics and
    electrochemical sensing.
  • Spectroscopic methods mainly involve Raman (or surface enhanced
    Raman) spectroscopy targeting the distinctive SARS-CoV 2 Raman
    spectrum, novel probes for fluorescence-based measurements, and
    state-of-the-art optical metasurfaces for detection.

To learn more about TechConnect Ventures' Innovation Sprints please contact Nick Kacsandi at


Sprint Response Metrics


Country Representation

 New Zealand

Development Status

 Proven Manufacturability
 Ready to Market
 Commercial Product



Organization Size


TRL Distribution


Organization Type


Twitter Website

© Copyright 2021 TechConnect. All Rights Reserved. Disclaimer | Privacy Policy | Terms of Use
All Department of Defense speakers are subject to budget travel changes.

*Participation by any United States Federal Agency in any TechConnect activity or event does not constitute an expressed or implied endorsement of any cosponsor, donor, grantee, contractor or participant’s opinions, products, or services.

Produced by


In Partnership with

TechConnect Ventures


COPD Foundation